Larkin Cristina
Known title: Chief Operating OfficerCIK: 0001721173
Associated companies
Transaction History
| SPRO | ▲ Buy | Grant | 38,014 | $0 | 2/1/2022 | View on chart |
| SPRO | ▲ Buy | Grant | 24,067 | $0 | 8/26/2021 | View on chart |
| SPRO | ▲ Buy | Grant | 38,014 | $0 | 2/1/2022 | View on chart |
| SPRO | ▲ Buy | Grant | 24,067 | $0 | 8/26/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
SPRO among stocks that gapped in Tuesday's session
Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.
SPRO among stocks that gapped in Tuesday's session. Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.